SDCCAG8 Antikörper (AA 321-420) (Cy5)
Kurzübersicht für SDCCAG8 Antikörper (AA 321-420) (Cy5) (ABIN721664)
Target
Alle SDCCAG8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 321-420
-
Homologie
- Human,Mouse,Rat,Cow,Sheep,Pig,Horse
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human SDCCAG8
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- SDCCAG8 (serologically Defined Colon Cancer Antigen 8 (SDCCAG8))
-
Andere Bezeichnung
- SDCCAG8
-
Hintergrund
-
Synonyms: Antigen NY CO 8, CCCAP, Centrosomal colon cancer autoantigen protein, HSPC085, NPHP10 gene, NY-CO-8, Serologically defined colon cancer antigen 8, Serologically defined colon cancer antigen 8 homolog, SLSN7 gene, SDCG8_HUMAN.
Background: The exact function of SDCCAG8 remains unknown. It is expressed in thymus, prostate, testis, ovary, small intestine, colon, mucosa, colon and renal cancer tumors.
-
Gen-ID
- 10806
-
Pathways
- M Phase, Tube Formation
Target
-